PMID: 11426465
These antiapoptotic mechanisms constitute vulnerabilities and, consequently, targeting them with either BCL2 family inhibitors 24,25,34 or via suppression of cFLIP 26 kills senescent cells
Springer Link , Archives of Disease in Childhood , vol
How They Compare Key Considerations Independent mechanisms: GHK-Cu and Tirzepatide work through different receptor systems, reducing interaction risk Complementary goals: GHK-Cu addresses skin anti-aging, wound remodeling, hair growth while Tirzepatide drives weight loss and metabolic improvement Physician supervision required: Any combination protocol should be designed and monitored by a licensed physician Sequential start: Begin one compound first, stabilize, then add the second to identify any individual reactions Frequently Asked Questions Is this combination safe
Clodi K, McDuff B, Zhao S, Kliche KO, Palmer JL, Cabanillas F, Andreeff M , Younes A
Lipid nanoparticles for mRNA delivery